Closing Bell: Stocks End Higher As Corporate Earnings Take Focus

Stocks remained in positive territory breaking a three-day losing streak ahead of U.S. corporate earnings this week, despite mounting tension between North Korea and the U.S. The financial sector led markets higher. Netflix (NFLX) - Get Report shares rose Monday as the streaming company is expected to report earnings of 37 cents a share on revenue of $2.64 billion after the closing bell.  Eli Lilly (LLY) - Get Report shares dropped, while Incyte's (INCY) - Get Report shares tumbled after the company's joint application for the once-daily oral medication for the treatment of moderate-to-severe rheumatoid arthritis, was rejected by the Food and Drug Administration. Finally, OncoMed Pharmaceuticals (OMED) - Get Report dropped over 17% after the bio-pharmaceutical company said the phase 2 trial of its drug for small cell lung cancer, didn't meet its primary or secondary endpoints.